In this video, health-care analyst David Williamson discusses Dendreon's recent third-quarter results. This video focuses on the good news in the report, as a number of positive trends have moved in Dendreon's favor. Watch and find out what made investors bid up shares as much as 30% intraday on Friday.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 10/25/2021.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
- Does This News Make Johnson & Johnson a Buy?
- What Could These Clinical Results Mean for AbbVie's Shareholders?
- These 3 Under-the-Radar Stocks Are Great Buys Right Now
- 3 Stocks to Add to Your Portfolio in the Event of a Market Downturn
- Adding $1,000 to These 3 Stocks Right Now Would Be a Brilliant Move